ProfileGDS5822 / ILMN_1240216
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 14% 7% 19% 8% 9% 42% 28% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.434
GSM1276600PDAC Late Ablation Control 213.114
GSM1276601PDAC Late Ablation Control 32.67
GSM1276602PDAC Late Ablation 11119
GSM1276603PDAC Late Ablation 27.58
GSM1276604PDAC Late Ablation 37.79
GSM1303940PDAC Late Ablation_anti-CTLA4 119.142
GSM1303941PDAC Late Ablation_anti-CTLA4 21428
GSM1303942PDAC Late Ablation_anti-CTLA4 39.918